SCHEMBL5465458

SCHEMBL5465458

CC1Oc2ccc(C(N)CCCCNC(=O)c3ccc(Cl)cc3)cc2NC1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMYD3 Q9H7B4 4/20 0.46
PARP1 P09874 5/20 0.44
KDR P35968 1/20 0.41
HSD17B10 Q99714 1/20 0.38
GAA P10253 1/20 0.37
THRB P10828 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5458540 0.99 SMYD3 (0.46) SMYD3PARP1KDRHSD17B10GAA
SCHEMBL5470029 0.91 SMYD3 (0.47) SMYD3PARP1KDRHSD17B10HDAC3
SCHEMBL5474586 0.83 PARP1 (0.40) SMYD3PARP1KDRHSD17B10GAA
SCHEMBL5471775 0.83 SMYD3 (0.42) SMYD3PARP1GAAPOLBSMN1; SMN2
SCHEMBL5853907 0.82 PARP1 (0.40) SMYD3PARP1KDRHSD17B10HDAC3
SCHEMBL5472598 0.82 SMYD3 (0.41) SMYD3PARP1GAATSHR
SCHEMBL5465443 0.81 PARP1 (0.56) SMYD3PARP1KDRGAATP53
SCHEMBL5458528 0.80 PARP1 (0.55) SMYD3PARP1KDRHDAC3HDAC4
Hydrochloric Acid SCHEMBL5473099 0.80 KMT2A (0.40) HDAC3HDAC4HDAC1HDAC7HDAC2
Hydrochloric Acid SCHEMBL5465710 0.79 KMT2A (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070049583-A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 2007-03-01 US disclosed
US-7141566-B1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments SCHERING AKTIENGESELLSCHAFT (DE) 2006-11-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049583-A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceutical agents CYP3A5, XDH, CYP4Z1 SMYD3 4613/4885PARP1 2890/4885KDR 4294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.